Request Demo
Last update 04 Oct 2025
LPM-3480226
Last update 04 Oct 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms LPM3480226, LY 01013, LY-01013 |
Target |
Action inhibitors |
Mechanism IDO1 inhibitors(Indoleamine 2,3-dioxygenase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with LPM-3480226CTR20182328
在晚期实体瘤患者中口服LPM3480226片的安全及耐受性、药代及药效动力学特征的非随机、开放、剂量递增的1期临床
[Translation] A non-randomized, open-label, dose-escalation phase 1 clinical trial evaluating the safety and tolerability, pharmacokinetics, and pharmacodynamics of oral LPM3480226 tablets in patients with advanced solid tumors.
NCT03844438
A Non-randomized, Open, Dose Escalation Phase 1 Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LPM3480226 Tablets in Patients With Advanced Solid Tumors
100 Clinical Results associated with LPM-3480226
Login to view more data
100 Translational Medicine associated with LPM-3480226
Login to view more data
100 Patents (Medical) associated with LPM-3480226
Login to view more data
100 Deals associated with LPM-3480226
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 07 Jan 2019 | |
| Bladder Cancer | Phase 1 | China | 07 Jan 2019 | |
| Head and Neck Neoplasms | Phase 1 | China | 07 Jan 2019 | |
| Kidney Neoplasms | Phase 1 | China | 07 Jan 2019 | |
| Lung Cancer | Phase 1 | China | 07 Jan 2019 | |
| Melanoma | Phase 1 | China | 07 Jan 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free